(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -4.14%6.69B | 9.01%13.93B | 17.22%6.98B | 10.63%12.78B | 9.79%5.96B | 3.15%11.55B | 4.98%5.42B | 2.47%11.19B | 1.41%5.17B | 7.82%10.93B |
Operating income | -4.14%6.69B | 9.01%13.93B | 17.22%6.98B | 10.63%12.78B | 9.79%5.96B | 3.15%11.55B | 4.98%5.42B | 2.47%11.19B | 1.41%5.17B | 7.82%10.93B |
Cost of sales | 3.63%-2.62B | -11.04%-5.63B | -20.07%-2.72B | -17.97%-5.07B | -13.11%-2.26B | -7.29%-4.3B | -15.25%-2B | -8.41%-4.01B | -3.88%-1.74B | -8.96%-3.7B |
Operating expenses | 3.63%-2.62B | -11.04%-5.63B | -20.07%-2.72B | -17.97%-5.07B | -13.11%-2.26B | -7.29%-4.3B | -15.25%-2B | -8.41%-4.01B | -3.88%-1.74B | -8.96%-3.7B |
Gross profit | -4.46%4.07B | 7.67%8.29B | 15.47%4.26B | 6.28%7.7B | 7.85%3.69B | 0.85%7.25B | -0.22%3.42B | -0.57%7.19B | 0.21%3.43B | 7.25%7.23B |
Selling expenses | -0.48%-2.65B | -6.96%-5.6B | -8.54%-2.64B | -5.30%-5.24B | -12.00%-2.43B | -7.99%-4.97B | -5.14%-2.17B | -2.46%-4.6B | -4.82%-2.07B | -21.33%-4.49B |
Administrative expenses | 1.59%-405.87M | -16.60%-848.45M | -30.97%-412.44M | -4.59%-727.68M | -1.22%-314.91M | -2.45%-695.72M | -9.43%-311.11M | -6.43%-679.06M | 5.04%-284.29M | -2.98%-638.02M |
Operating interest expense | ---- | ---- | ---- | ---- | -94.18%-252.28M | 0.49%-285.14M | 13.46%-129.92M | 31.90%-286.55M | ---150.12M | ---420.76M |
Special items of operating profit | -181.75%-42.8M | 24.95%-121.85M | 658.20%52.36M | 63.60%-162.35M | 93.41%-9.38M | -2,012.90%-445.97M | -331.50%-142.36M | 82.06%-21.11M | 91.23%61.5M | 71.35%-117.67M |
Operating profit | -23.10%969.86M | 9.25%1.72B | 85.04%1.26B | 85.83%1.58B | 2.24%681.6M | -46.79%849.28M | -32.73%666.68M | 2.41%1.6B | -16.34%991M | -22.30%1.56B |
Financing cost | -21.02%-433.25M | -47.15%-773.49M | ---358M | ---525.66M | ---- | ---- | ---- | ---- | ---- | ---- |
Share of profits of associates | -15,163.86%-12.67M | 20.56%-17.19M | 58.50%-83K | -2,421.14%-21.63M | -105.81%-200K | -88.93%932K | -32.90%3.45M | 29.91%8.42M | 95.43%5.13M | 398.46%6.48M |
Earning before tax | -41.99%523.94M | -9.44%933.6M | 32.54%903.15M | 21.26%1.03B | 1.68%681.4M | -47.02%850.21M | -32.73%670.13M | 2.52%1.6B | -0.54%996.13M | 2.44%1.57B |
Tax | 26.09%-218.14M | 16.08%-351.76M | -43.07%-295.14M | -22.66%-419.15M | -22.23%-206.29M | 26.98%-341.73M | 39.32%-168.77M | 16.46%-467.97M | 3.59%-278.13M | 18.20%-560.15M |
After-tax profit from continuing operations | -49.70%305.8M | -4.89%581.85M | 27.97%608.01M | 20.32%611.78M | -5.23%475.11M | -55.27%508.48M | -30.17%501.35M | 13.10%1.14B | 0.69%718.01M | 19.20%1.01B |
Earning after tax | -49.70%305.8M | -4.89%581.85M | 27.97%608.01M | 20.32%611.78M | -5.23%475.11M | -55.27%508.48M | -30.17%501.35M | 13.10%1.14B | 0.69%718.01M | 19.20%1.01B |
Profit attributable to shareholders | -49.70%305.8M | -4.89%581.85M | 27.97%608.01M | 20.32%611.78M | -5.23%475.11M | -55.27%508.48M | -30.17%501.35M | 13.10%1.14B | 0.69%718.01M | 19.20%1.01B |
Basic earnings per share | -49.47%0.48 | -5.21%0.91 | 28.38%0.95 | 21.52%0.96 | -5.13%0.74 | -55.37%0.79 | -30.36%0.78 | 12.74%1.77 | 0.90%1.12 | 18.94%1.57 |
Diluted earnings per share | -49.47%0.48 | -5.26%0.9 | 28.38%0.95 | 20.25%0.95 | -5.13%0.74 | -55.11%0.79 | -29.73%0.78 | 13.55%1.76 | 0.91%1.11 | 19.23%1.55 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data